Literature DB >> 10393912

Functional interaction between human topoisomerase IIalpha and retinoblastoma protein.

U G Bhat1, P Raychaudhuri, W T Beck.   

Abstract

DNA topoisomerase II-an essential nuclear enzyme in DNA replication and transcription, chromatin segregation, and cell cycle progression-is also a target of clinically useful anticancer drugs. Preliminary observations of a positive correlation between the expression of topoisomerase (topo) IIalpha and the retinoblastoma protein (Rb) in a series of rhabdomyosarcoma cells prompted us to ask whether these two proteins interact in vivo. Using human rhabdomyosarcoma and leukemic cell lines, we found a physical association between topo IIalpha and Rb protein by reciprocal immunoprecipitation and immunoblotting, in which topo IIalpha appeared to interact primarily with the underphosphorylated form of Rb. Experiments with truncated glutathione S-transferase-Rb fusion proteins and nuclear extracts of Rh1 rhabdomyosarcoma cells indicated that topo IIalpha binds avidly to the A/B pocket domain of Rb, which contains the intact spacer amino acid sequence. To determine whether this interaction has functional consequences in vivo, we expressed wild-type and mutant Rb in human cervical carcinoma cells lacking functional Rb. Wild-type, but not mutant, Rb inhibited topo II activity in nuclear extracts of these transfected cells. Moreover, purified wild-type Rb inhibited the activity of purified human topo IIalpha, indicating a direct interaction between these two proteins. We conclude that topo IIalpha associates physically with Rb in interactions that appear to have functional significance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393912      PMCID: PMC22152          DOI: 10.1073/pnas.96.14.7859

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Sgs1: a eukaryotic homolog of E. coli RecQ that interacts with topoisomerase II in vivo and is required for faithful chromosome segregation.

Authors:  P M Watt; E J Louis; R H Borts; I D Hickson
Journal:  Cell       Date:  1995-04-21       Impact factor: 41.582

2.  DNA topoisomerase II and casein kinase II associate in a molecular complex that is catalytically active.

Authors:  K Bojanowski; O Filhol; C Cochet; E M Chambaz; A K Larsen
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

3.  Growth state- and cell cycle-dependent fluctuation in the expression of two forms of DNA topoisomerase II and possible specific modification of the higher molecular weight form in the M phase.

Authors:  K Kimura; M Saijo; M Ui; T Enomoto
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

4.  A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle.

Authors:  P J Welch; J Y Wang
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

Review 5.  The retinoblastoma protein: more than a tumor suppressor.

Authors:  D J Riley; E Y Lee; W H Lee
Journal:  Annu Rev Cell Biol       Date:  1994

Review 6.  The retinoblastoma tumor suppressor protein.

Authors:  J Y Wang; E S Knudsen; P J Welch
Journal:  Adv Cancer Res       Date:  1994       Impact factor: 6.242

Review 7.  Structure and function of type II DNA topoisomerases.

Authors:  P M Watt; I D Hickson
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

8.  Induction of low density lipoprotein receptor and a transcription factor SP-1 by tumor necrosis factor in human microvascular endothelial cells.

Authors:  R Hamanaka; K Kohno; T Seguchi; K Okamura; A Morimoto; M Ono; J Ogata; M Kuwano
Journal:  J Biol Chem       Date:  1992-07-05       Impact factor: 5.157

9.  Modification of DNA topoisomerase II activity via direct interactions with the cyclic adenosine-3',5'-monophosphate response element-binding protein and related transcription factors.

Authors:  D J Kroll; D M Sullivan; A Gutierrez-Hartmann; J P Hoeffler
Journal:  Mol Endocrinol       Date:  1993-03

Review 10.  Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme.

Authors:  D A Burden; N Osheroff
Journal:  Biochim Biophys Acta       Date:  1998-10-01
View more
  11 in total

1.  Involvement of retinoblastoma protein and HBP1 in histone H1(0) gene expression.

Authors:  C Lemercier; K Duncliffe; I Boibessot; H Zhang; A Verdel; D Angelov; S Khochbin
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  Aberrant lamination in the cerebral cortex of mouse embryos lacking DNA topoisomerase IIbeta.

Authors:  Yi Lisa Lyu; James C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-28       Impact factor: 11.205

3.  A gene recommender algorithm to identify coexpressed genes in C. elegans.

Authors:  Art B Owen; Josh Stuart; Kathy Mach; Anne M Villeneuve; Stuart Kim
Journal:  Genome Res       Date:  2003-08       Impact factor: 9.043

4.  Transcriptional consequences of topoisomerase inhibition.

Authors:  I Collins; A Weber; D Levens
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

5.  Human cells compromised for p53 function exhibit defective global and transcription-coupled nucleotide excision repair, whereas cells compromised for pRb function are defective only in global repair.

Authors:  J P Therrien; R Drouin; C Baril; E A Drobetsky
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

6.  The retinoblastoma tumor suppressor protein is required for efficient processing and repair of trapped topoisomerase II-DNA-cleavable complexes.

Authors:  Hai Xiao; David W Goodrich
Journal:  Oncogene       Date:  2005-12-08       Impact factor: 9.867

7.  Novel regulation of nuclear factor-YB by miR-485-3p affects the expression of DNA topoisomerase IIα and drug responsiveness.

Authors:  Cheng-Fen Chen; Xiaolong He; Ahmet Dirim Arslan; Yin-Yuan Mo; William C Reinhold; Yves Pommier; William T Beck
Journal:  Mol Pharmacol       Date:  2011-01-20       Impact factor: 4.436

8.  RNA helicase A interacts with dsDNA and topoisomerase IIalpha.

Authors:  Kai Zhou; Kyoo-Tae Choe; Zaheer Zaidi; Qi Wang; Michael B Mathews; Chee-Gun Lee
Journal:  Nucleic Acids Res       Date:  2003-05-01       Impact factor: 16.971

9.  Interaction between tumor suppressor adenomatous polyposis coli and topoisomerase IIalpha: implication for the G2/M transition.

Authors:  Yang Wang; Yoshiaki Azuma; David Moore; Neil Osheroff; Kristi L Neufeld
Journal:  Mol Biol Cell       Date:  2008-07-16       Impact factor: 4.138

10.  HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIalpha.

Authors:  Michal Stros; Eva Polanská; Sona Struncová; Sárka Pospísilová
Journal:  Nucleic Acids Res       Date:  2009-02-17       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.